Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

  1. Baracco, E.E.
  2. Pietrocola, F.
  3. Buqué, A.
  4. Bloy, N.
  5. Senovilla, L.
  6. Zitvogel, L.
  7. Vacchelli, E.
  8. Kroemer, G.
Journal:
OncoImmunology

ISSN: 2162-402X 2162-4011

Year of publication: 2016

Volume: 5

Issue: 6

Type: Article

DOI: 10.1080/2162402X.2016.1139275 GOOGLE SCHOLAR lock_openOpen access editor